Rocket Lab Secures Multiple Billion-Dollar Contracts, Shares Jump 6% on Jan. 9

RKLBRKLB

Rocket Lab's shares rose 6.03% on Jan. 9 after it secured multiple billion-dollar contracts and grew its launch backlog, reflecting accelerating sales momentum. However, stretched valuation ratios pose the key risk that could stall further gains despite rapid launch success.

1. Surge Driven by Increased Launch Cadence

Rocket Lab completed 22 orbital launches in 2025, up from 12 the prior year, driving a 48% increase in launch revenue. The company’s Electron rocket maintained a 95% mission success rate, allowing Rocket Lab to cut turnaround time between flights to just 30 days. This ramped-up activity contributed to a 173.9% share price gain for the full year, reflecting investor confidence in Rocket Lab’s ability to scale operations efficiently.

2. Billion-Dollar Contracts Fuel Backlog Growth

Throughout 2025, Rocket Lab secured three contracts valued at over $1.2 billion combined, including a $720 million agreement with a national space agency for dedicated Electron launches through 2028 and a $510 million deal to deploy a constellation of 24 small satellites. These awards have boosted the company’s contracted backlog to $2.5 billion, representing a 65% increase year-over-year and ensuring revenue visibility into 2029.

3. Valuation Stretch Raises Investor Concerns

Despite robust operational metrics, Rocket Lab’s price-to-sales multiple expanded from 8x at the start of 2025 to 18x by January 2026. Analysts warn that, while SpaceX’s potential $1.5 trillion initial public valuation has raised sector sentiment, Rocket Lab must deliver on profitability targets—projected net losses narrowing from $80 million in 2025 to $30 million in 2027—to justify its elevated valuation and sustain the current rally.

Sources

FF